IRIS
MALCOVATI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.244
AS - Asia 4.739
EU - Europa 3.526
SA - Sud America 811
AF - Africa 96
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 14
Totale 15.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.116
CN - Cina 2.438
SG - Singapore 1.067
IE - Irlanda 863
HK - Hong Kong 738
BR - Brasile 675
UA - Ucraina 429
RU - Federazione Russa 428
FI - Finlandia 427
DE - Germania 391
IT - Italia 335
VN - Vietnam 209
SE - Svezia 192
GB - Regno Unito 189
CA - Canada 65
FR - Francia 57
AR - Argentina 50
IN - India 45
JP - Giappone 44
AT - Austria 41
MX - Messico 41
NL - Olanda 36
BD - Bangladesh 32
PL - Polonia 30
ZA - Sudafrica 29
TR - Turchia 27
ES - Italia 25
BE - Belgio 24
IQ - Iraq 22
EC - Ecuador 21
ID - Indonesia 16
PY - Paraguay 14
VE - Venezuela 13
CO - Colombia 12
IL - Israele 12
AU - Australia 11
KE - Kenya 11
EU - Europa 10
PE - Perù 10
CZ - Repubblica Ceca 9
LT - Lituania 9
UZ - Uzbekistan 9
CL - Cile 8
KR - Corea 8
PK - Pakistan 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
EG - Egitto 7
CH - Svizzera 6
MU - Mauritius 6
NG - Nigeria 6
SA - Arabia Saudita 6
CR - Costa Rica 5
MA - Marocco 5
DK - Danimarca 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
OM - Oman 4
PS - Palestinian Territory 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
GH - Ghana 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
MN - Mongolia 2
MR - Mauritania 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BF - Burkina Faso 1
Totale 15.421
Salva come PNG Salva come JPEG
Città #
Chandler 911
Dublin 862
Hong Kong 738
Dallas 584
Jacksonville 583
Nanjing 524
Ashburn 518
Singapore 435
Boardman 375
Beijing 362
Princeton 210
Nanchang 197
Lawrence 196
Medford 187
Wilmington 170
Los Angeles 156
Changsha 153
New York 153
Hebei 145
Shenyang 138
Jiaxing 119
Buffalo 115
Helsinki 115
Redondo Beach 90
Tianjin 88
Ann Arbor 84
Milan 82
Hangzhou 80
Ho Chi Minh City 77
Moscow 76
Shanghai 72
Munich 71
Pavia 66
The Dalles 57
São Paulo 56
Seattle 53
Hanoi 47
Nuremberg 46
Woodbridge 38
Tokyo 37
Norwalk 35
Turku 35
Toronto 31
Chicago 30
Washington 30
Warsaw 29
Belo Horizonte 28
San Francisco 28
Brooklyn 26
Brussels 24
Fairfield 22
Santa Clara 22
Verona 21
Guangzhou 20
Jinan 20
Denver 19
Columbus 18
London 18
Montreal 18
Zhengzhou 18
Boston 17
Orem 17
Falls Church 16
Poplar 16
Brasília 15
Stockholm 15
Johannesburg 14
Kunming 14
Rio de Janeiro 14
Vienna 14
Amsterdam 13
Ankara 13
Chennai 13
Des Moines 13
Haiphong 13
Falkenstein 12
Mexico City 12
Atlanta 11
Dearborn 11
Frankfurt am Main 11
Nairobi 11
Redwood City 11
Houston 10
Ningbo 10
Rome 10
Phoenix 9
Ribeirão Preto 9
Campinas 8
Charlotte 8
Curitiba 8
Fuzhou 8
Juiz de Fora 8
Porto Alegre 8
Shenzhen 8
Taizhou 8
Tashkent 8
Wuhan 8
Asunción 7
Baku 7
Chengdu 7
Totale 10.003
Salva come PNG Salva come JPEG
Nome #
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 147
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 131
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 130
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 128
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 122
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 122
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 121
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 120
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 118
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 115
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 113
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 113
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 111
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 110
Classification and prognostic evaluation of myelodysplastic syndromes 110
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 109
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 109
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. 107
Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010. 101
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 100
Clinical significance of somatic mutation in unexplained blood cytopenia 99
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 98
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 98
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 98
Myelodysplastic syndromes: diagnosis and staging. 95
Clinical and biological implications of driver mutations in myelodysplastic syndromes 95
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 95
Revised international prognostic scoring system for myelodysplastic syndromes 95
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 91
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 90
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. 89
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 88
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 88
Myelodysplastic syndromes--coping with ineffective hematopoiesis. 88
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 88
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 88
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 87
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 87
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 87
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 86
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 86
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 86
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. 86
Appreci8: A pipeline for precise variant calling integrating 8 tools 86
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 85
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 84
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 84
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms 84
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. 84
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives 83
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 83
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. 83
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 83
Relationship between clone metrics and clinical outcome in clonal cytopenia 82
Hematologic passport for athletes competing in endurance sports: a feasibility study. 82
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms 82
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 81
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. 81
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 81
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing 80
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 80
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 80
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 78
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 77
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 77
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 77
Myelodysplastic/myeloproliferative disorders 77
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 77
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 77
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 77
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 77
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 76
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 75
Simian virus 40 and lymphoproliferative disorder. 75
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 75
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 75
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease 75
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 74
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 74
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications 74
Cerebral vasoreactivity in Andeans and headache at sea level. 73
Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes. 73
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 73
Genetic and clinical heterogeneity of ferroportin disease. 73
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. 73
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 73
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 72
Haematological modifications after acute exposure to high altitude: possible implications for detenction of recombinant erythropoietin misure 72
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. 71
Myelodysplastic/myeloproliferative neoplasms 71
Novel homeobox gene recombination in T-cell acute lymphoblastic leukemia. 71
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet 71
Pan-cancer analysis of whole genomes 71
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 70
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 70
Splenectomy for treatment of immune thrombocytopenic purpura. 70
The genetic basis of myelodysplasia and its clinical relevance 70
Risk factors for Gram-negative infections in neutropenic patients. 70
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. 69
Myelodysplastic syndromes with bone marrow fibrosis. 69
Totale 8.785
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021586 0 0 0 0 0 91 46 152 28 140 95 34
2021/2022917 15 4 15 15 34 34 12 42 57 34 143 512
2022/20232.553 272 138 20 234 248 264 2 165 1.050 25 96 39
2023/20241.160 85 199 58 78 113 327 29 69 10 23 78 91
2024/20253.174 75 286 106 84 72 195 203 228 653 170 366 736
2025/20264.031 544 693 909 919 866 100 0 0 0 0 0 0
Totale 15.915